believed that in addition to the importance of having scientists and clinicians working side by side there was a need in his department for some individuals who could combine skills in research and clinical practice. He took the position that 'scientific rigor and traditional humanitarianism are complementary aspects of medicine' and that some individuals must attempt 'to embrace both points of view.'3 He thought that the mysteries ofjoint diseases might be solved by study of connective tissue macromolecules, and with this aim he recruited young scientists interested in collagen, mucopolysaccharides and glycoproteins to work with him, while at the same time he helped and encouraged them to establish their own independence. Two Short, Bauer, and Reynolds4 had just completed a detailed long-term study of rheumatoid arthritis, and described the nature of this chronic inflammatory disease. I had become interested in how collagen is degraded in physiological as well as pathological bone resorption, and with encouragement from Jerome Gross I tried to identify collagenase activity in bone homogenates, but was unsuccessful. About that time Gross had begun to investigate the mechanisms of limb regeneration in amphibia (see review by Gross5). He too had been unable to find an enzyme in extracts of tadpole tissues capable of degrading native collagen at neutral pH and physiological temperature. He reasoned that, at any one time, the concentration of the putative enzyme might be below limits of detection, possibly because of binding to tissue collagen. With Charles Lapiere he then devised an organ culture system using tissue explants placed on collagen gels and discovered that the collagen was lysed around these fragments of living tissue.6 Subsequent studies proved that the tissue released a specific collagenase capable of cleaving native collagen across the 3 chains of the 433 group.bmj.com on June 1, 2017 -Published by http://ard.bmj.com/ Downloaded from 434 Krane helical molecules at a point 3/4 the distance from the amino terminal end (Fig. 1 ).57 By 1966 it was possible to begin to explore some of the mechanisms ofjoint destruction in rheumatoid arthritis adapting approaches then being developed in Gross's laboratory. John Evanson joined the Arthritis Unit at that time and in collaboration with John Jeffrey we cultured fragments of rheumatoid synovium and found that all samples examined produced a collagenase with properties similar to those described for the amphibian enzyme.8 9 1974 . We reasoned that culturing fibroblasts from explants, using conventional methodology, selects for cells which can grow well in artificial, serum-supplemented media. This method of obtaining fibroblasts from synovium might select against more slowly growing cells which could retain the capacity to produce high levels of collagenase. In order to avoid the negative selective effects of growing cells from explants we therefore dispersed the cells from synovectomy specimens using sequential digestion with clostridial collagenase and trypsin.2223 Although a variable percentage of these dispersed cells adhere to the culture vessel surface, all of the measureable collagenase and most of the prostaglandin are produced by these adherent cells. We were impressed that during the first 1-2 weeks of culture the predominant adherent cells are quite large (20-30 ,um or greater in diameter) stellate in form, and with several branching processes (Fig. 3) studies of Wahl et Effiect of immunoglobulin on MCF production by peripheral blood monocytes. Conditions were similar to those described in Fig. 8 (Fig. 10) . These stimulating effects of indomethacin are then reversed by additions of exogenous PGE2 during the preincubation (Fig. 11) . Furthermore, the addition of both indomethacin and MCF shifts the doseresponse curve to the left and lowers the threshold concentration of exogenous PGE2 necessary for eliciting an increase in cAMP content.35 It thus appears that MCF acts directly to alter the sensitivity of the synovial cells to PGE2. As yet, we have no direct measurements of PGE2 binding to support our hypothesis that this increase in sensitivity most likely involves an increase in either the number of PGE2 receptors or an alteracion in binding affinity. How this could be accomplished is not known, but it is tempting to speculate that some change in the structure of the plasma membrane is responsible. Cells were incubated for 3 days in medium alone (Control), MCF partially purified by gel filtration, indomethacin (Indo) 14 Prostaglandins synthesised by synovial cells in this cell culture system act in turn to affect additional cellular functions. Collagenase production is itself responsive to changes in endogenous PGE2 levels, although in many cultures marked inhibition of PGE2 synthesis does not alter release of the protease.74 89 In other cultures, indomethacin blunts, but does not abolish, the collagenase response to MCF. Under the latter circumstances, addition of small amounts of exogenous PGE2 restores the collagenase response. We are not certain what characteristic of the synovial cell cultures determines the indomethacin effects on collagenase. The behaviour of the human rheumatoid synovial cell cultures, however, is very different from that of rodent macrophages. Wahl et al.90 observed that when the latter are incubated with endotoxin, collagenase levels markedly increase but the increase is totally blocked by indomethacin. Addition of PGEI, PGE2, or dibutyryl cAMP then restores collagenase production.8991 I propose that the failure of indomethacin to regularly suppress collagenase production in the rheumatoid synovial cell cultures could be explained by an increased sensitivity to PGE2 (heterologous and homologous sensitisation of PGE2 receptors) as previously discussed.
Other synthetic functions of the cultured synovial cells modified by MCF and prostaglandins include synthesis of connective tissue macromolecules such as collagens and fibronectin. Levels of labelled medium proteins in cultures of cells incubated with labelled amino acids are increased by MCF.92 93 The major high molecular weight bands seen on SDS-PAGE are collagens (type I and III) and fibronectin. Addition of indomethacin in the absence of MCF enhances collagen and fibronectin synthesis. The presence of both MCF and indomethacin further enhances synthesis. Addition of small amounts of exogenous PGE2 then suppresses the stimulation, suggesting a regulatory role for PGE2 in macromolecule synthesis (Fig. 12) from those studied in our synovial cell model. One of these products is lymphocyte activating factor (LAF), also known as interleukin 1.42 43 94 We have just reported that highly purified preparations of murine LAF have biological activity similar to that of MCF in the rheumatoid synovial culture system and, conversely, partially purified preparations of human MCF have LAF activity.39 Furthermore, both preparations are inactivated by papain in 8M urea and by the arginine reagent, phenyl glyoxal. That MCF and LAF are identical has not been established, however, and it remains possible that the 2 activities could be attributable to similar polypeptides with sequence homologies or to distinct molecules with overlapping biological properties. The situation could be analogous to that recently described for the interferons.95 96 Interferons are members of a family of genes. These genes code for proteins which have amino acid sequence homologies, yet are distinct from each other. These differences in structure, in turn, result in different biological properties. Thus, until we obtain amino acid sequences, and even the sequences of the genomic DNA that code for the respective polypeptides, we cannot resolve the question of identity of molecules which have been characterised mainly on the basis of specific but restricted biological properties. The relationship of MCF to factors produced by rheumatoid synovium such as those described by Dingle97 and Meats, McGuire, and Russell98 therefore, is also yet to be determined. 5. Although our understanding of the detailed mechanisms of the complex interactions in this model system is incomplete, we hope eventually to use the information derived to design more novel therapeutic approaches than are currently available to deal with the destructive lesion which characterises rheumatoid arthritis. 
